HIV prevention injection successful in South Africa trial

AllAfrica - Top Africa News — July 1, 2024, 11:00 AM UTC

Summary: A pivotal trial in South Africa showed a highly effective HIV prevention injection, lenacapavir, providing six months of protection per shot. The injection outperformed prevention pills, with 0 new HIV infections in the lenacapavir group. Concerns remain about access and pricing, with hopes for quicker availability than previous treatments. Gilead aims to expedite regulatory approval and licensing for broader access.

Full article

Article metrics

Significance6.1

Scale & Impact0.0

Positivity9.0

Credibility7.8

What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

[4.4]
Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
99d 16h
Source
[5.1]
UNAIDS urges global access to new HIV drug Lenacapavir (Marketscreener.com)
102d 18h
Scores Source
[6.3]
New HIV prevention drug lenacapavir shows 100% efficacy (ScienceAlert)
103d 19h
Scores Source
[4.6]
Biannual Lenacapavir injection 100% effective against HIV (WION)
105d 18h
Source
[5.8]
Lenacapavir injection offers 100% HIV protection to young women (Hindustan Times)
106d 12h
Scores Source
[5.2]
HIV prevention drug lenacapavir safe and effective in trial (The East African)
107d 13h
Scores Source